This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Research

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

Francesco Benedetti, Laura Sforzini, Cristina Colombo, Cesare Maffei, and Enrico Smeraldi

Published: March 15, 1998

Article Abstract

Background: Psychotic-like symptoms in patientsaffected by borderline personality disorder (BPD) are usuallytreated with low-dose neuroleptics, which show controversialacute effects and lead to a worsening of affective-relatedsymptoms and to severe neurologic side effects after prolongedadministration. Clozapine lacks the neurologic side effects oftraditional neuroleptics and has been shown to successfully treatpsychotic-like symptoms in BPD patients at medium dose. Weperformed an open-label trial of low-dose clozapine in severe BPDpatients.

Method: Twelve BPD inpatients (DSM-IV criteria)with severe psychotic-like symptoms were studied. Exclusioncriteria included comorbid Axis I and medical pathologies. Allpatients had followed a therapeutic program without improvementfor at least 4 months before admission. The clozapine dose wastitrated upward on an individual basis until the completedisappearance of psychotic-like symptoms was achieved.Clinician-rated scales were completed at the beginning of thestudy and after 4 and 16 weeks.

Results: All patients completed the 16-weekstudy. Individual clozapine doses ranged from 25 to 100 mg/day.Psychotic-like symptoms decreased within the first 3 weeks oftreatment, as confirmed by a statistically significant decreasein Brief Psychiatric Rating Scale scores. This amelioration wascoupled with an overall improvement, including a reduction inimpulsive behaviors and in affective-related symptoms (HamiltonRating Scale for Depression) and an increase in globalfunctioning (Global Assessment of Functioning).

Conclusion: Low-dose clozapine for acute andcontinuation treatment led to improvement in overallsymptomatology in a small sample of severe BPD patients.

Volume: 59

Quick Links:

Continue Reading…

Subscribe to read the entire article


Buy this Article as a PDF